These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 15273118

  • 1. Inhibitors of Leishmania mexicana CRK3 cyclin-dependent kinase: chemical library screen and antileishmanial activity.
    Grant KM, Dunion MH, Yardley V, Skaltsounis AL, Marko D, Eisenbrand G, Croft SL, Meijer L, Mottram JC.
    Antimicrob Agents Chemother; 2004 Aug; 48(8):3033-42. PubMed ID: 15273118
    [Abstract] [Full Text] [Related]

  • 2. The CRK3 protein kinase is essential for cell cycle progression of Leishmania mexicana.
    Hassan P, Fergusson D, Grant KM, Mottram JC.
    Mol Biochem Parasitol; 2001 Apr 06; 113(2):189-98. PubMed ID: 11295173
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Recombinant Leishmania mexicana CRK3:CYCA has protein kinase activity in the absence of phosphorylation on the T-loop residue Thr178.
    Gomes FC, Ali NO, Brown E, Walker RG, Grant KM, Mottram JC.
    Mol Biochem Parasitol; 2010 Jun 06; 171(2):89-96. PubMed ID: 20338198
    [Abstract] [Full Text] [Related]

  • 7. 2,6,9-Trisubstituted purines as CRK3 kinase inhibitors with antileishmanial activity in vitro.
    Řezníčková E, Popa A, Gucký T, Zatloukal M, Havlíček L, Bazgier V, Berka K, Jorda R, Popa I, Nasereddin A, Jaffe CL, Kryštof V, Strnad M.
    Bioorg Med Chem Lett; 2015 Jun 01; 25(11):2298-301. PubMed ID: 25937014
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Identification of inhibitors of the Leishmania cdc2-related protein kinase CRK3.
    Cleghorn LA, Woodland A, Collie IT, Torrie LS, Norcross N, Luksch T, Mpamhanga C, Walker RG, Mottram JC, Brenk R, Frearson JA, Gilbert IH, Wyatt PG.
    ChemMedChem; 2011 Dec 09; 6(12):2214-24. PubMed ID: 21913331
    [Abstract] [Full Text] [Related]

  • 11. Novel fragment-based QSAR modeling and combinatorial design of pyrazole-derived CRK3 inhibitors as potent antileishmanials.
    Goyal S, Dhanjal JK, Tyagi C, Goyal M, Grover A.
    Chem Biol Drug Des; 2014 Jul 09; 84(1):54-62. PubMed ID: 24447365
    [Abstract] [Full Text] [Related]

  • 12. Activity of hydroxyurea against Leishmania mexicana.
    Martinez-Rojano H, Mancilla-Ramirez J, Quiñonez-Diaz L, Galindo-Sevilla N.
    Antimicrob Agents Chemother; 2008 Oct 09; 52(10):3642-7. PubMed ID: 18694950
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Evaluation of the in vitro and in vivo antileishmanial activity of a chloroquinolin derivative against Leishmania species capable of causing tegumentary and visceral leishmaniasis.
    Soyer TG, Mendonça DVC, Tavares GSV, Lage DP, Dias DS, Ribeiro PAF, Perin L, Ludolf F, Coelho VTS, Ferreira ACG, Neves PHAS, Matos GF, Chávez-Fumagalli MA, Coimbra ES, Pereira GR, Coelho EAF, Antinarelli LMR.
    Exp Parasitol; 2019 Apr 09; 199():30-37. PubMed ID: 30817917
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. In vitro and in vivo antileishmanial activity of 2-amino-4,6-dimethylpyridine derivatives against Leishmania mexicana.
    Abdala H, Alvarez N, Delmas F, Di Giorgio C, Robert JM, Le Baut G, Le Pape P.
    Parasite; 2002 Dec 09; 9(4):367-70. PubMed ID: 12514953
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Effect of DODAB Nano-Sized Cationic Bilayer Fragments against Leishmania amazonensis.
    Ferreira TCS, Sauter IP, Borda-Samper L, Bentivoglio E, DaMata JP, Taniwaki NN, Orrego PR, Araya JE, Lincopan N, Cortez M.
    Molecules; 2020 Dec 05; 25(23):. PubMed ID: 33291367
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.